Phathom Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.887; its P/E ratio is -2.44; Phathom Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-1.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 682.00K	-	-	-	-
Gross Profit	$ 515.00K	-	-	-	-
EBIT	$ -66.37M	$ -33.14M	$ -31.35M	$ -28.60M	$ -46.73M
EBITDA	$ -65.62M	$ -32.47M	$ -30.95M	$ -27.95M	$ -46.07M
Net Income Common Stockholders	$ -79.57M	$ -43.24M	$ -40.97M	$ -37.81M	$ -55.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 381.39M	$ 213.68M	$ 248.85M	$ 129.57M	$ 155.38M
Total Assets	$ 413.84M	$ 236.99M	$ 265.04M	$ 142.74M	$ 164.81M
Total Debt	$ 139.03M	$ 100.61M	$ 99.31M	$ 98.30M	$ 97.07M
Net Debt	$ -242.36M	$ -113.07M	$ -149.53M	$ -31.28M	$ -58.31M
Total Liabilities	$ 486.60M	$ 254.76M	$ 247.44M	$ 234.21M	$ 239.62M
Stockholders Equity	$ -72.76M	$ -17.77M	$ 17.60M	$ -90.19M	$ -74.81M
Cash Flow	-
Free Cash Flow	$ -44.27M	$ -32.85M	$ -22.21M	$ -39.88M	$ -41.11M
Operating Cash Flow	$ -43.80M	$ -31.91M	$ -22.20M	$ -39.67M	$ -40.70M
Investing Cash Flow	$ -475.00K	$ -939.00K	$ -6.00K	$ -214.00K	$ -412.00K
Financing Cash Flow	$ 211.99M	$ 13.00K	$ 141.50M	$ 14.07M	-

Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

Income Statement >

Phathom Pharmaceuticals Debt to Assets

Balance Sheet >

Phathom Pharmaceuticals Cash Flow

Cash Flow >

Phathom Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing